Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer

Background: Increased serum neuron-specific enolase (NSE) level was found in a substantial proportion (30–69%) of patients with non-small-cell lung cancer (NSCLC), but little was known about the clinical properties of NSE in NSCLC. Objective: We aimed to assess the level of serum NSE to predict prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Peng, Han, Yiming, Tong, Anna, Liu, Jie, Wang, Xinyu, Liu, Chuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329647/
https://www.ncbi.nlm.nih.gov/pubmed/34286335
http://dx.doi.org/10.1042/BSR20210866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329647/
https://www.ncbi.nlm.nih.gov/pubmed/34286335
http://dx.doi.org/10.1042/BSR20210866

Ejemplares similares